Stryker NTX Registry Scorpio NRG (Re-"Energize"), Triathlon Total Knee, Triathlon Partial Knee Resurfacing (PKR) With X3 Polyethylene Insert

NCT02525562 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 237

Last updated 2024-02-22

Study results available
· View outcomes & findings →

Summary

Provide outcomes information with regard to surgical and implant performance and patient clinical outcomes of the patients who are eligible for either a Total Knee Arthroplasty (TKA) replacement surgery or Partial Knee Resurfacing (unicompartmental knee arthroplasty, UKA)

Conditions

  • Arthroplasty, Replacement, Knee

Interventions

DEVICE

Triathlon Total Knee System with X3 insert

Total knee replacement

DEVICE

Scorpio NRG Total Knee System with X3 insert

Total knee replacement

DEVICE

Triathlon PKR System with X3 insert

Partial Knee Resurfacing

PROCEDURE

Total Knee Replacement

Total Knee Replacement

PROCEDURE

Partial Knee Resurfacing

Partial Knee Resurfacing

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Romain Seil, MD · Centre Hospitalier du Luxembourg

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-28
Primary Completion
2020-05-28
Completion
2020-05-28
FDA Device
Yes

Countries

  • Germany
  • Luxembourg
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02525562 on ClinicalTrials.gov